首页 | 本学科首页   官方微博 | 高级检索  
     


Comparative efficacy and safety of gemigliptin versus linagliptin in type 2 diabetes patients with renal impairment: A 40‐week extension of the GUARD randomized study
Authors:Sang Youb Han MD  PhD  Sun Ae Yoon MD  PhD  Byoung Geun Han MD  PhD  Sung Gyun Kim MD  PhD  Young‐Il Jo MD  PhD  Kyung Hwan Jeong MD  PhD  Kook‐Hwan Oh MD  PhD  Hyeong Cheon Park MD  PhD  Sun‐Hee Park MD  PhD  Shin‐Wook Kang MD  PhD  Ki‐Ryang Na MD  PhD  Sun Woo Kang MD  PhD  Nam‐Ho Kim MD  PhD  Younghwan Jang BS  Bogyeong Kim MS  Seonghye Shin MS  Dae Ryong Cha MD  PhD
Affiliation:1. Department of Internal Medicine, Inje University Ilsan Paik Hospital, Goyang, Republic of Korea;2. Department of Internal Medicine, Catholic University Uijeongbu St. Mary's Hospital, Uijeongbu, Republic of Korea;3. Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, Republic of Korea;4. Department of Internal Medicine, Hallym University Sacred Heart Hospital, Anyang, Republic of Korea;5. Department of Internal Medicine, Konkuk University School of Medicine, Seoul, Republic of Korea;6. Department of Internal Medicine, Kyung Hee University School of Medicine, Seoul, Republic of Korea;7. Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea;8. Department of Internal Medicine, Gangnam Severance Hospital, Seoul, Republic of Korea;9. Department of Internal Medicine, Kyungpook National University School of Medicine, Daegu, Republic of Korea;10. Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea;11. Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Republic of Korea;12. Department of Nephrology, Busan Paik Hospital Inje University, Busan, Republic of Korea;13. Department of Internal Medicine, Chonnam National University College of Medicine, Gwangju, Republic of Korea;14. LG Life Sciences, Seoul, Republic of Korea;15. Department of Internal Medicine, Korea University Ansan Hospital, Ansan, Republic of Korea
Abstract:
Keywords:diabetic nephropathy  DPP‐IV inhibitor  phase III study  type 2 diabetes mellitus
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号